Actually, I don't. I have been having some conversations with the leaders of some of the country's pharmaceutical companies and some of them around the world. And I think What you're actually going to see with most favored nation, you're going to have a stabilizing cost, a true appreciation of the cost of medicine and the cost of R&D into the future. as opposed to what we now have, is the United States. And our people are subsidizing that cost for everybody else. (59:27–59:43)
CLAIM
Asserts that the most favored nation policy will stabilize and clarify medicine and R&D costs.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.